20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Qiagen NV (QGEN) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Venlo, Netherlands with about 5,500 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, QGEN reported $2.1B in revenue and $425M in net income.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide.
Interactive charts & full statements → Open the QGEN valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.1B | $2.1B | $2.0B | $2.0B | $2.1B | $2.3B | $1.9B | $1.5B | $1.5B | $1.4B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.1B | $1.0B | $893M | $650M | $466M |
| Gross Profit | $1.3B | $1.3B | $967M | $1.2B | $1.4B | $1.5B | $1.2B | $1.0B | $1.0B | $923M | $845M | $827M | $865M | $815M | $824M | $750M | $716M | $667M | $600M | $434M | $325M |
| Gross Margin % | 61.8% | 61.8% | 48.9% | 62.8% | 64.6% | 64.4% | 65.9% | 65.9% | 66.6% | 65.1% | 63.1% | 64.5% | 64.3% | 62.6% | 65.7% | 64.1% | 65.8% | 66.1% | 67.2% | 66.7% | 69.7% |
| Operating Income (EBIT) | $541M | $520M | $98M | $410M | $531M | $630M | $386M | ($26M) | $267M | $153M | $99M | $179M | $162M | $63M | $170M | $100M | $189M | $180M | $146M | $83M | $101M |
| Operating Margin % | 25.8% | 24.9% | 4.9% | 20.9% | 24.8% | 28.0% | 20.7% | -1.7% | 17.8% | 10.8% | 7.4% | 14.0% | 12.0% | 4.9% | 13.5% | 8.5% | 17.3% | 17.8% | 16.3% | 12.8% | 21.6% |
| Net Income | $409M | $425M | $84M | $341M | $423M | $513M | $359M | ($41M) | $190M | $40M | $80M | $130M | $116M | $69M | $130M | $96M | $144M | $138M | $89M | $50M | $71M |
| Net Margin % | 19.5% | 20.3% | 4.2% | 17.4% | 19.8% | 22.8% | 19.2% | -2.7% | 12.7% | 2.9% | 6.0% | 10.2% | 8.6% | 5.3% | 10.3% | 8.2% | 13.3% | 13.6% | 10.0% | 7.7% | 15.1% |
| EBITDA | — | $717M | $368M | $689M | $779M | $895M | $716M | $228M | $499M | $381M | $309M | $365M | $360M | $268M | $366M | $289M | $344M | $322M | $263M | $195M | $140M |
| Earnings Per Share (EPS) | $1.95 | $2.04 | $0.38 | $1.57 | $1.90 | $2.28 | $1.58 | $-0.19 | $0.82 | $0.17 | $0.35 | $0.57 | $0.50 | $0.30 | $0.56 | $0.42 | $0.62 | $0.67 | $0.45 | $0.30 | $0.48 |
| Shares Outstanding (M) | — | 208M | 218M | 217M | 223M | 225M | 227M | 220M | 233M | 233M | 230M | 228M | 233M | 233M | 232M | 230M | 232M | 206M | 197M | 169M | 148M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $535M | $492M | $540M | $533M | $534M | $483M | $521M | $502M | $496M |
| Gross Profit | $340M | $310M | $317M | $331M | $334M | $309M | $333M | $308M | $35M |
| Gross Margin % | 63.5% | 62.9% | 58.7% | 62.2% | 62.6% | 63.8% | 63.9% | 61.4% | 7.0% |
| Operating Income (EBIT) | $141M | $117M | $154M | $129M | $122M | $115M | $119M | $112M | ($228M) |
| Operating Margin % | 26.4% | 23.7% | 28.5% | 24.2% | 22.9% | 23.9% | 22.9% | 22.3% | -46.0% |
| Net Income | $103M | $68M | $108M | $130M | $96M | $91M | $88M | $98M | ($183M) |
| Net Margin % | 19.2% | 13.8% | 20.0% | 24.4% | 18.0% | 18.8% | 17.0% | 19.5% | -37.0% |
| EBITDA | — | $148M | $169M | $277M | $184M | $171M | $183M | $178M | ($159M) |
| Earnings Per Share (EPS) | $0.50 | $0.33 | $0.52 | $0.60 | $0.44 | $0.41 | $0.41 | $0.44 | $-0.83 |
| Shares Outstanding (M) | — | 209M | 208M | 218M | 218M | 220M | 218M | 224M | 222M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $655M | $654M | $674M | $459M | $715M | $639M | $492M | $331M | $359M | $287M | $342M | $317M | $288M | $259M | $245M | $245M | $251M | $217M | $173M | $85M | $101M |
| Capital Expenditures (CapEx) | $207M | $201M | $167M | $163M | $149M | $207M | $304M | $275M | $151M | $124M | $94M | $117M | $97M | $119M | $128M | $121M | $124M | $69M | $58M | $59M | $35M |
| Free Cash Flow (FCF) | $447M | $453M | $506M | $297M | $566M | $432M | $188M | $56M | $209M | $162M | $248M | $200M | $191M | $140M | $117M | $123M | $127M | $148M | $115M | $26M | $66M |
| FCF Margin % | 21.3% | 21.7% | 25.6% | 15.1% | 26.4% | 19.2% | 10.1% | 3.7% | 13.9% | 11.5% | 18.5% | 15.6% | 14.2% | 10.8% | 9.3% | 10.5% | 11.7% | 14.6% | 12.9% | 4.0% | 14.2% |
| Dividends Paid | — | $54M | $0M | $0M | $25M | — | $622M | — | $567M | $770M | — | — | $786M | $0M | $400M | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $201M | $101M | $188M | $165M | $161M | $140M | $192M | $182M | $167M |
| Capital Expenditures (CapEx) | $43M | $47M | $71M | $46M | $41M | $44M | $50M | $44M | $39M |
| Free Cash Flow (FCF) | $157M | $54M | $117M | $119M | $121M | $96M | $142M | $138M | $128M |
| FCF Margin % | 29.3% | 10.9% | 21.7% | 22.3% | 22.6% | 19.8% | 27.2% | 27.5% | 25.7% |
| Dividends Paid | — | — | $0M | $54M | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.9B | $6.3B | $5.7B | $6.1B | $6.3B | $6.1B | $5.9B | $5.2B | $5.7B | $5.0B | $4.3B | $4.2B | $4.5B | $4.1B | $4.1B | $3.8B | $3.9B | $3.8B | $2.9B | $2.8B | $1.2B |
| Cash & Cash Equivalents | $768M | $839M | $664M | $668M | $731M | $881M | $598M | $624M | $1.2B | $658M | $439M | $293M | $396M | $333M | $402M | $228M | $855M | $826M | $333M | $347M | $430M |
| Total Liabilities | $2.5B | $2.5B | $2.1B | $2.3B | $2.8B | $3.0B | $3.1B | $2.7B | $3.1B | $2.5B | $1.7B | $1.6B | $1.8B | $1.4B | $1.4B | $1.2B | $1.4B | $1.5B | $1.4B | $1.4B | $646M |
| Total Debt (Short + Long-Term) | $1.6B | $1.7B | $1.4B | $1.5B | $1.9B | $2.0B | $1.9B | $1.7B | $2.2B | $1.8B | $1.1B | $1.1B | $1.2B | $862M | $867M | $594M | $900M | $952M | $979M | $986M | $509M |
| Total Shareholders' Equity | $3.4B | $3.8B | $3.6B | $3.8B | $3.5B | $3.1B | $2.8B | $2.5B | $2.6B | $2.5B | $2.6B | $2.6B | $2.6B | $2.7B | $2.7B | $2.5B | $2.5B | $2.3B | $1.5B | $1.4B | $566M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QGEN viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms